Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Ibrutinib and Itraconazole in Chronic Graft Versus Host Disease
NCT05348096Phase 2Unknown
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Apr 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibrutinib in chronic graft-versus-host disease (cGVHD), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Status: unknown.
02
Drugs
ibrutinib
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT05348096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05348096.